BioCryst Pharmaceuticals | Aktywa



Assets Zmiana Data
Alnylam Pharmaceuticals USD 4.21B 26.17M 2025-03
Chugai Pharma JPY 2.14T 68.89B 2025-03
Daiichi Sankyo JPY 3.46T 12.51B 2025-03
DBV Technologies USD 50.56M 15.1M 2025-03
Gilead Sciences USD 56.43B 2.56B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Glaxosmithkline GBP 59.46B 1.41B 2024-12
Incyte USD 5.75B 305.04M 2025-03
Ionis Pharmaceuticals USD 2.81B 190.73M 2025-03
Neurocrine Biosciences USD 3.72B 183.7M 2024-12
PTC Therapeutics USD 2.66B 950.36M 2025-03
Regeneron Pharmaceuticals USD 37.55B 214.2M 2025-03
Roche Holding CHF 101.8B 6.02B 2024-12
Sarepta Therapeutics USD 3.47B 497.79M 2025-03
Ultragenyx Pharmaceutical USD 1.31B 191.53M 2025-03
Vertex Pharmaceuticals USD 22.53B 293M 2024-12



BioCryst Pharmaceuticals Aktywa - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - Jul 2025.